Following is a cumulative list of Hoosier Cancer Research Network publications in hepatocellular carcinoma (liver cancer).

Manuscripts and Journal Articles

• E. Gabriela Chiorean, Rashmi Ramasubbaiah, Menggang Yu, Joel Picus, Jose A. Bufill, Yan Tong, Nicki Coleman, Erica L. Johnston, Colleen Currie, Patrick J. Loehrer. Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101. Oncologist. 2012 January; 17(1): 13. doi: 10.1634/ theoncologist.2011-0253 PMCID: PMC3267812
• Miller K, Loehrer PJ, Gonin R, Weber G, Ansari R, Pletcher W, McClean J, Spiridonidis CH, Mortimer J: Phase II Study of Weekly Oral Methotrexate and Zidovudine (AZT) in Advanced Adenocarcinoma of the Pancreas and Hepatocellular Carcinoma: Hoosier Oncology Group GI91-1. Invest New Drugs 14:207-212, 1996.

Abstracts, Posters, and Presentations

• AR He, AY Kim, BM Toskich, K Mody, K Kim, S Stein, L Goyal, TA Abrams, D Brown, LW Goff, RD Kim, N Parikh, T Sandow, D Johnson, RV Iyer, M Petroziello, SS Krishnamurthi, C Martin, Y Jiang, N Akhter. A phase II study of atezolizumab (ATEZO) and bevacizumab (Bev) in combination with Y90 TARE in patients (Pts) with hepatocellular carcinoma (HCC): HCRN GI19-405. Presented as a Trials in Progress Poster at the 2021 Gastrointestinal Cancers Symposium. See abstract.